Aggressive use of prophylactic cerebrospinal fluid drainage to prevent spinal cord ischemia during thoracic endovascular aortic repair is not supportive.


Journal

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
ISSN: 1873-734X
Titre abrégé: Eur J Cardiothorac Surg
Pays: Germany
ID NLM: 8804069

Informations de publication

Date de publication:
03 11 2022
Historique:
received: 27 05 2022
revised: 18 08 2022
pubmed: 6 9 2022
medline: 10 11 2022
entrez: 5 9 2022
Statut: ppublish

Résumé

We investigated whether prophylactic preoperative cerebrospinal fluid drainage (CSFD) was effective in preventing spinal cord ischemia (SCI) during thoracic endovascular aortic repair of degenerative descending thoracic aortic aneurysms, excluding dissecting aneurysms. We retrospectively reviewed the medical records of patients who underwent thoracic endovascular aortic repair involving proximal landing zones 3 and 4 between 2009 and 2020. Eighty-nine patients with preemptive CSFD [68 men; median (range) age, 76.0 (71.0-81.0) years] and 115 patients without CSFD [89 men; median (range) age, 77.0 (74.0-81.5) years] were included in this study. Among them, 59 from each group were matched based on propensity scores to regulate for differences in backgrounds. The incidence rate of SCI was similar: 8/89 (9.0%) in the CSFD group and 6/115 (5.2%) in the non-CSFD group (P = 0.403). Shaggy aorta (odds ratio, 5.13; P = 0.004) and iliac artery access (odds ratio, 5.04; P = 0.005) were identified as positive predictors of SCI. Other clinically important confounders included Adamkiewicz artery coverage (odds ratio, 2.53; P = 0.108) and extensive stent graft coverage (>8 vertebrae) (odds ratio, 1.41; P = 0.541) were not statistically significant. Propensity score matching yielded similar incidence of SCI: 4/59 (6.8%) in the CSFD group and 3/59 (5.1%) in the non-CSFD group (P = 0.697). Aggressive use of prophylactic CSFD was not supportive in patients without complex risks of SCI.

Identifiants

pubmed: 36063039
pii: 6692307
doi: 10.1093/ejcts/ezac441
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Auteurs

Yoshimasa Seike (Y)

Department of Cardiovascular Surgery, National Cerebral and Cardiovascular Center, Osaka, Japan.

Tetsuya Fukuda (T)

Department of Radiology, National Cerebral and Cardiovascular Center, Osaka, Japan.

Koki Yokawa (K)

Department of Cardiovascular Surgery, National Cerebral and Cardiovascular Center, Osaka, Japan.

Shigeki Koizumi (S)

Department of Cardiovascular Surgery, National Cerebral and Cardiovascular Center, Osaka, Japan.

Kenta Masada (K)

Department of Cardiovascular Surgery, National Cerebral and Cardiovascular Center, Osaka, Japan.

Yosuke Inoue (Y)

Department of Cardiovascular Surgery, National Cerebral and Cardiovascular Center, Osaka, Japan.

Hitoshi Matsuda (H)

Department of Cardiovascular Surgery, National Cerebral and Cardiovascular Center, Osaka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH